These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 16021534)
1. A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma. van Poll D; Thompson JF; Colman MH; McKinnon JG; Saw RP; Stretch JR; Scolyer RA; Uren RF Ann Surg Oncol; 2005 Aug; 12(8):597-608. PubMed ID: 16021534 [TBL] [Abstract][Full Text] [Related]
2. Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma. Kang JC; Wanek LA; Essner R; Faries MB; Foshag LJ; Morton DL J Clin Oncol; 2005 Jul; 23(21):4764-70. PubMed ID: 16034052 [TBL] [Abstract][Full Text] [Related]
3. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma. Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497 [TBL] [Abstract][Full Text] [Related]
4. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732 [TBL] [Abstract][Full Text] [Related]
5. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755 [TBL] [Abstract][Full Text] [Related]
6. [Prognosis after sentinel node biopsy in malignant melanoma]. Lock-Andersen J; Horn J; Sjøstrand H Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370 [TBL] [Abstract][Full Text] [Related]
7. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection. Rutkowski P; Nowecki ZI; Zurawski Z; Dziewirski W; Nasierowska-Guttmejer A; Switaj T; Ruka W Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835 [TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study. Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169 [TBL] [Abstract][Full Text] [Related]
9. High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma. Estourgie SH; Nieweg OE; Kroon BB Br J Surg; 2004 Oct; 91(10):1370-1. PubMed ID: 15376178 [TBL] [Abstract][Full Text] [Related]
10. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal experience and literature meta-analysis. Pasquali S; Mocellin S; Campana LG; Bonandini E; Montesco MC; Tregnaghi A; Del Fiore P; Nitti D; Rossi CR Cancer; 2010 Mar; 116(5):1201-9. PubMed ID: 20066719 [TBL] [Abstract][Full Text] [Related]
11. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Nowecki ZI; Rutkowski P; Michej W Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535 [TBL] [Abstract][Full Text] [Related]
12. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]. de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183 [TBL] [Abstract][Full Text] [Related]
13. The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy. Zapas JL; Coley HC; Beam SL; Brown SD; Jablonski KA; Elias EG J Am Coll Surg; 2003 Sep; 197(3):403-7. PubMed ID: 12946795 [TBL] [Abstract][Full Text] [Related]
14. Patterns of recurrence in patients with melanoma after radical lymph node dissection. Nathansohn N; Schachter J; Gutman H Arch Surg; 2005 Dec; 140(12):1172-7. PubMed ID: 16365238 [TBL] [Abstract][Full Text] [Related]
15. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma. van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089 [TBL] [Abstract][Full Text] [Related]
16. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Livestro DP; Kaine EM; Michaelson JS; Mihm MC; Haluska FG; Muzikansky A; Sober AJ; Tanabe KK Cancer; 2007 Aug; 110(3):614-24. PubMed ID: 17577228 [TBL] [Abstract][Full Text] [Related]
17. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Scheri RP; Essner R; Turner RR; Ye X; Morton DL Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497 [TBL] [Abstract][Full Text] [Related]
18. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. Thomas JM; Clark MA Eur J Surg Oncol; 2004 Aug; 30(6):686-91. PubMed ID: 15256245 [TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004. Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331 [TBL] [Abstract][Full Text] [Related]
20. Sentinel node identification by scintigraphic methods in cutaneous melanoma. Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]